| Field | Row 1 |
|---|---|
| adsh | 0001410578-25-001296 |
| cik | 1867066 |
| name | JOURNEY MEDICAL CORP |
| sic | 2834 |
| countryba | US |
| stprba | AZ |
| cityba | SCOTTSDALE |
| zipba | 85258 |
| bas1 | 9237 E VIA DE VENTURA BLVD., SUITE 105 |
| bas2 | |
| baph | 480-434-6670 |
| countryma | US |
| stprma | AZ |
| cityma | SCOTTSDALE |
| zipma | 85258 |
| mas1 | 9237 E VIA DE VENTURA BLVD., SUITE 105 |
| mas2 | |
| countryinc | US |
| stprinc | DE |
| ein | 471879539 |
| former | |
| changed | |
| afs | 4-NON |
| wksi | 0 |
| fye | 1231 |
| form | 10-Q |
| period | 20250331 |
| fy | 2025 |
| fp | Q1 |
| filed | 20250515 |
| accepted | 2025-05-15 06:02:00.0 |
| prevrpt | 0 |
| detail | 1 |
| instance | derm-20250331x10q_htm.xml |
| nciks | 1 |
| aciks |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| cik | Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings. |
| name | Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date. |
| sic | Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business. |
| countryba | The ISO 3166-1 country of the registrant's business address. |
| stprba | The state or province of the registrant’s business address, if field countryba is US or CA. |
| cityba | The city of the registrant's business address. |
| zipba | The zip code of the registrant’s business address. |
| bas1 | The first line of the street of the registrant’s business address. |
| bas2 | The second line of the street of the registrant’s business address. |
| baph | The phone number of the registrant’s business address. |
| countryma | The ISO 3166-1 country of the registrant's mailing address. |
| stprma | The state or province of the registrant’s mailing address, if field countryma is US or CA. |
| cityma | The city of the registrant's mailing address. |
| zipma | The zip code of the registrant’s mailing address. |
| mas1 | The first line of the street of the registrant’s mailing address. |
| mas2 | The second line of the street of the registrant’s mailing address. |
| countryinc | The ISO 3166-1 country of incorporation for the registrant. |
| stprinc | The state or province of incorporation for the registrant, if countryinc is US or CA. |
| ein | Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States. |
| former | Most recent former name of the registrant, if any. |
| changed | Date of change from the former name, if any. |
| afs | Filer status with the SEC at the time of submission: 1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned. |
| wksi | Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement. |
| fye | Fiscal Year End Date, rounded to nearest month-end. |
| form | The submission type of the registrant’s filing. |
| period | Balance Sheet Date, rounded to nearest month-end. |
| fy | Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8). |
| fp | Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year. |
| filed | The date of the registrant’s filing with the Commission. |
| accepted | The acceptance date and time of the registrant’s filing with the Commission. |
| prevrpt | Previous Report – TRUE indicates that the submission information was subsequently amended. |
| detail | TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount). |
| instance | The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol. |
| nciks | Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing. |
| aciks | Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information. |
| adsh | ddate | tag | value | uom | qtrs | version | segments | coreg | footnote |
|---|---|---|---|---|---|---|---|---|---|
| 0001410578-25-001296 | 20250331 | Accounts Payable Current | 14404000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20250331 | Accrued Income Taxes Current | 59000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20250331 | Amortization Of Intangible Assets | 1100000.0000 | USD | 1 | us-gaap/2024 | Concentration Risk By Benchmark= Cost Of Goods Total; | ||
| 0001410578-25-001296 | 20250331 | Cash And Cash Equivalents At Carrying Value | 21070000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20250331 | Common Stock Shares Authorized | 50000000.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Common Excluding Class; | ||
| 0001410578-25-001296 | 20241231 | Common Stock Shares Issued | 6000000.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Common Class A; | ||
| 0001410578-25-001296 | 20241231 | Common Stock Shares Outstanding | 6000000.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Common Class A; | ||
| 0001410578-25-001296 | 20241231 | Common Stock Shares Outstanding | 16153610.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Common Excluding Class; | ||
| 0001410578-25-001296 | 20241231 | Common Stock Value | 1000.0000 | USD | 0 | us-gaap/2024 | Class Of Stock= Common Class A; | ||
| 0001410578-25-001296 | 20240331 | Costs And Expenses | 23472000.0000 | USD | 1 | us-gaap/2024 | Consolidation Items= Operating Segments; | ||
| 0001410578-25-001296 | 20240331 | Earnings Per Share Basic | -0.5300 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20250331 | Increase Decrease In Accounts Receivable | 7989000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20250331 | Increase Decrease In Inventories | -1935000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20241231 | Liabilities | 60172000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20250331 | Net Cash Provided By Used In Financing Activities | 3597000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20250331 | Net Income Loss | -4073000.0000 | USD | 1 | us-gaap/2024 | Consolidation Items= Operating Segments; | ||
| 0001410578-25-001296 | 20250331 | Operating Income Loss | -3324000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20250331 | Operating Lease Liability Noncurrent | 94000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20240331 | Proceeds From Issuance Of Common Stock | 1484000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20250331 | Research And Development Expense | 39000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20241231 | Retained Earnings Accumulated Deficit | -87027000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 13139000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20240331 | Selling General And Administrative Expense | 8420000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20231231 | Shares Outstanding | 6000000.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Common Class A; Equity Components= Common Stock; | ||
| 0001410578-25-001296 | 20241231 | Shares Outstanding | 6000000.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Common Class A; Equity Components= Common Stock; | ||
| 0001410578-25-001296 | 20241231 | Shares Outstanding | 16153610.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001410578-25-001296 | 20231231 | Stockholders Equity | 92703000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001410578-25-001296 | 20231231 | Stockholders Equity | -72355000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001410578-25-001296 | 20240331 | Stockholders Equity | 1000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001410578-25-001296 | 20240331 | Stock Issued During Period Shares New Issues | 289744.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001410578-25-001296 | 20240331 | Stock Issued During Period Shares Stock Options Exercised | 55375.0000 | shares | 1 | us-gaap/2024 | Award Type= Employee Stock Option; | ||
| 0001410578-25-001296 | 20250331 | Stock Issued During Period Value Employee Stock Purchase Plan | 99000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20250331 | Stock Issued During Period Value New Issues | 4048000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20250331 | Stock Issued During Period Value New Issues | 4048000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001410578-25-001296 | 20241231 | Accounts Receivable Net Current | 10231000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20241231 | Accrued Liabilities Current | 17425000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20250331 | Additional Paid In Capital | 112639000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 1323000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20250331 | Assets | 84962000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20241231 | Assets Current | 48179000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20241231 | Commitments And Contingencies | USD | 0 | us-gaap/2024 | ||||
| 0001410578-25-001296 | 20250331 | Common Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | Class Of Stock= Common Excluding Class; | ||
| 0001410578-25-001296 | 20241231 | Common Stock Shares Authorized | 50000000.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Common Excluding Class; | ||
| 0001410578-25-001296 | 20250331 | Common Stock Shares Authorized | 50000000.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Common Class A; | ||
| 0001410578-25-001296 | 20250331 | Common Stock Value | 1000.0000 | USD | 0 | us-gaap/2024 | Class Of Stock= Common Excluding Class; | ||
| 0001410578-25-001296 | 20250331 | Earnings Per Share Diluted | -0.1800 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20240331 | Increase Decrease In Accounts Payable | -2806000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20250331 | Increase Decrease In Accrued Income Taxes Payable | -1000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20250331 | Increase Decrease In Operating Lease Liability | -14000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20241231 | Intangible Assets Net Excluding Goodwill | 31863000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20250331 | Interest Paid Net | 813000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20241231 | Inventory Net | 14431000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20240331 | Net Cash Provided By Used In Operating Activities | -5019000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20240331 | Nonoperating Income Expense | -352000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20241231 | Operating Lease Liability Current | 83000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20241231 | Other Liabilities Current | 528000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20240331 | Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans | 85000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20250331 | Proceeds From Stock Options Exercised | 75000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20250331 | Research And Development Expense | 39000.0000 | USD | 1 | us-gaap/2024 | Consolidation Items= Operating Segments; | ||
| 0001410578-25-001296 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 1166000.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Other Legacy; | ||
| 0001410578-25-001296 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 3655000.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Accutane; | ||
| 0001410578-25-001296 | 20250331 | Shares Outstanding | 17104437.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001410578-25-001296 | 20240331 | Stockholders Equity | 12951000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20240331 | Stockholders Equity | -82797000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001410578-25-001296 | 20241231 | Stockholders Equity | 1000.0000 | USD | 0 | us-gaap/2024 | Class Of Stock= Common Class A; Equity Components= Common Stock; | ||
| 0001410578-25-001296 | 20250331 | Stockholders Equity | 112639000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001410578-25-001296 | 20250331 | Stock Issued During Period Shares New Issues | 834722.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001410578-25-001296 | 20240331 | Cost Of Goods And Service Excluding Depreciation Depletion And Amortization | 6002000.0000 | USD | 1 | us-gaap/2024 | Consolidation Items= Operating Segments; | ||
| 0001410578-25-001296 | 20240331 | Costs And Expenses | 23120000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20250331 | Costs And Expenses | 17212000.0000 | USD | 1 | us-gaap/2024 | Consolidation Items= Operating Segments; | ||
| 0001410578-25-001296 | 20240331 | Foreign Currency Transaction Gain Loss Before Tax | -21000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20240331 | Increase Decrease In Accrued Income Taxes Payable | -16000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20250331 | Liabilities And Stockholders Equity | 84962000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20250331 | Long Term Debt Current | 1875000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20241231 | Long Term Debt Noncurrent | 24879000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20250331 | Net Income Loss | -4073000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001410578-25-001296 | 20250331 | Operating Lease Liability Current | 93000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20250331 | Prepaid Expense And Other Assets Current | 2395000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20240331 | Proceeds From Stock Options Exercised | 68000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20240331 | Proceeds From Stock Options Exercised | 67514000.0000 | USD | 1 | us-gaap/2024 | Award Type= Employee Stock Option; | ||
| 0001410578-25-001296 | 20250331 | Provision For Doubtful Accounts | 195000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20240331 | Research And Development Expense | 7884000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20250331 | Stockholders Equity | 21541000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20250331 | Stockholders Equity | 1000.0000 | USD | 0 | us-gaap/2024 | Class Of Stock= Common Class A; Equity Components= Common Stock; | ||
| 0001410578-25-001296 | 20240331 | Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures | 211028.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001410578-25-001296 | 20250331 | Stock Issued During Period Shares Stock Options Exercised | 40043.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001410578-25-001296 | 20240331 | Stock Issued During Period Value Employee Stock Purchase Plan | 85000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20240331 | Stock Issued During Period Value New Issues | 1484000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001410578-25-001296 | 20250331 | Weighted Average Number Of Diluted Shares Outstanding | 22611040.0000 | shares | 1 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20241231 | Accounts Payable Current | 16050000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20241231 | Assets | 80241000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20241231 | Cash And Cash Equivalents At Carrying Value | 20305000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20241231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 20305000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | 765000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20250331 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -4073000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20250331 | Increase Decrease In Interest Payable Net | -23000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20240331 | Increase Decrease In Inventories | 374000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20240331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | -1011000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20240331 | Interest Expense Nonoperating | 548000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20240331 | Interest Paid Net | 267000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20250331 | Liabilities | 63421000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20241231 | Operating Lease Right Of Use Asset | 199000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20240331 | Operating Lease Right Of Use Asset Amortization Expense | 22000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20250331 | Profit Loss | -4073000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20250331 | Repayments Of Notes Payable | 625000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20240331 | Research And Development Expense | 7884000.0000 | USD | 1 | us-gaap/2024 | Consolidation Items= Operating Segments; | ||
| 0001410578-25-001296 | 20231231 | Stockholders Equity | 20350000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20250331 | Stock Issued During Period Shares Stock Options Exercised | 40043.0000 | shares | 1 | us-gaap/2024 | Award Type= Employee Stock Option; | ||
| 0001410578-25-001296 | 20240331 | Stock Issued During Period Value Stock Options Exercised | 68000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20240331 | Stock Issued During Period Value Stock Options Exercised | 68000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001410578-25-001296 | 20250331 | Accounts Receivable Net Current | 18025000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20250331 | Amortization Of Intangible Assets | 1065000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20241231 | Common Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | Class Of Stock= Common Excluding Class; | ||
| 0001410578-25-001296 | 20250331 | Common Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | Class Of Stock= Common Class A; | ||
| 0001410578-25-001296 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 1323000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001410578-25-001296 | 20250331 | Amortization Of Debt Discount Premium | 101000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20240331 | Amortization Of Intangible Assets | 800000.0000 | USD | 1 | us-gaap/2024 | Concentration Risk By Benchmark= Cost Of Goods Total; | ||
| 0001410578-25-001296 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 24057000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20250331 | Commitments And Contingencies | USD | 0 | us-gaap/2024 | ||||
| 0001410578-25-001296 | 20241231 | Common Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | Class Of Stock= Common Class A; | ||
| 0001410578-25-001296 | 20241231 | Common Stock Shares Issued | 16153610.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Common Excluding Class; | ||
| 0001410578-25-001296 | 20250331 | Cost Of Goods And Service Excluding Depreciation Depletion And Amortization | 4790000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20250331 | Earnings Per Share Basic | -0.1800 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20250331 | Increase Decrease In Account Payable Related Party | -129000.0000 | USD | 1 | 0001410578-25-001296 | |||
| 0001410578-25-001296 | 20240331 | Increase Decrease In Interest Payable Net | 219000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20240331 | Interest Income | 217000.0000 | USD | 1 | 0001410578-25-001296 | |||
| 0001410578-25-001296 | 20250331 | Interest Payable Current | 381000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20250331 | Long Term Debt Noncurrent | 23105000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20240331 | Net Cash Provided By Used In Financing Activities | 1637000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20241231 | Other Liabilities Current | 500000.0000 | USD | 0 | us-gaap/2024 | Related Party Transaction= Shared Services Agreement With Fortress; Schedule Of Equity Method Investment Equity Method Investee Name= Fortress; | ||
| 0001410578-25-001296 | 20250331 | Other Liabilities Current | 400000.0000 | USD | 0 | us-gaap/2024 | Related Party Transaction= Shared Services Agreement With Fortress; Schedule Of Equity Method Investment Equity Method Investee Name= Fortress; | ||
| 0001410578-25-001296 | 20241231 | Prepaid Expense And Other Assets Current | 3212000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 5819000.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Accutane; | ||
| 0001410578-25-001296 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 5017000.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Qbrexza; | ||
| 0001410578-25-001296 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 426000.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Zilxi; | ||
| 0001410578-25-001296 | 20240331 | Share Based Compensation | 1406000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20240331 | Shares Outstanding | 6000000.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Common Class A; Equity Components= Common Stock; | ||
| 0001410578-25-001296 | 20231231 | Stockholders Equity | 1000.0000 | USD | 0 | us-gaap/2024 | Class Of Stock= Common Class A; Equity Components= Common Stock; | ||
| 0001410578-25-001296 | 20231231 | Stockholders Equity | 1000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001410578-25-001296 | 20240331 | Stockholders Equity | 95746000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001410578-25-001296 | 20241231 | Stockholders Equity | 1000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001410578-25-001296 | 20250331 | Stockholders Equity | -91100000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001410578-25-001296 | 20240331 | Stock Issued During Period Shares Employee Stock Purchase Plans | 52211.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001410578-25-001296 | 20250331 | Stock Issued During Period Shares Employee Stock Purchase Plans | 25641.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001410578-25-001296 | 20250331 | Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures | 50421.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001410578-25-001296 | 20240331 | Stock Issued During Period Value Employee Stock Purchase Plan | 85000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001410578-25-001296 | 20250331 | Weighted Average Number Of Shares Outstanding Basic | 22611040.0000 | shares | 1 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20241231 | Additional Paid In Capital | 107094000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 1406000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20231231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 27439000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20241231 | Common Stock Shares Authorized | 50000000.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Common Class A; | ||
| 0001410578-25-001296 | 20241231 | Common Stock Value | 1000.0000 | USD | 0 | us-gaap/2024 | Class Of Stock= Common Excluding Class; | ||
| 0001410578-25-001296 | 20250331 | Common Stock Value | 1000.0000 | USD | 0 | us-gaap/2024 | Class Of Stock= Common Class A; | ||
| 0001410578-25-001296 | 20250331 | Costs And Expenses | 16463000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20240331 | Earnings Per Share Diluted | -0.5300 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20250331 | Foreign Currency Transaction Gain Loss Before Tax | -7000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20240331 | Increase Decrease In Operating Lease Liability | -24000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20241231 | Installment Payments Licenses Net Current | 625000.0000 | USD | 0 | 0001410578-25-001296 | |||
| 0001410578-25-001296 | 20250331 | Interest Expense Nonoperating | 891000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20241231 | Liabilities And Stockholders Equity | 80241000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20250331 | Net Cash Provided By Used In Operating Activities | -2832000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20240331 | Net Income Loss | -10442000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20240331 | Net Income Loss | -10442000.0000 | USD | 1 | us-gaap/2024 | Consolidation Items= Operating Segments; | ||
| 0001410578-25-001296 | 20250331 | Operating Lease Right Of Use Asset Amortization Expense | 21000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 727000.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Other Legacy; | ||
| 0001410578-25-001296 | 20240331 | Stockholders Equity | 1000.0000 | USD | 0 | us-gaap/2024 | Class Of Stock= Common Class A; Equity Components= Common Stock; | ||
| 0001410578-25-001296 | 20250331 | Stock Issued During Period Value Stock Options Exercised | 75000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20250331 | Stock Issued During Period Value Stock Options Exercised | 75000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001410578-25-001296 | 20240331 | Weighted Average Number Of Shares Outstanding Basic | 19757449.0000 | shares | 1 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20241231 | Accrued Income Taxes Current | 60000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20240331 | Amortization Of Debt Discount Premium | 62000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20250331 | Common Stock Shares Issued | 17104437.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Common Excluding Class; | ||
| 0001410578-25-001296 | 20250331 | Common Stock Shares Outstanding | 17104437.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Common Excluding Class; | ||
| 0001410578-25-001296 | 20250331 | Increase Decrease In Accounts Payable | -1646000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20240331 | Increase Decrease In Accrued Liabilities | -317000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20250331 | Increase Decrease In Accrued Liabilities | 5586000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20250331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | -817000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20250331 | Interest Income | 149000.0000 | USD | 1 | 0001410578-25-001296 | |||
| 0001410578-25-001296 | 20250331 | Liabilities Current | 40222000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20250331 | Net Income Loss | -4073000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20250331 | Nonoperating Income Expense | -749000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20240331 | Operating Income Loss | -10090000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20250331 | Proceeds From Stock Options Exercised | 74886000.0000 | USD | 1 | us-gaap/2024 | Award Type= Employee Stock Option; | ||
| 0001410578-25-001296 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 13030000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 273000.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Zilxi; | ||
| 0001410578-25-001296 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 5161000.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Qbrexza; | ||
| 0001410578-25-001296 | 20240331 | Sale Of Stock Stock Issuance Costs | 46000.0000 | USD | 1 | 0001410578-25-001296 | |||
| 0001410578-25-001296 | 20250331 | Sale Of Stock Stock Issuance Costs | 125000.0000 | USD | 1 | 0001410578-25-001296 | |||
| 0001410578-25-001296 | 20250331 | Share Based Compensation | 1323000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20250331 | Shares Outstanding | 6000000.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Common Class A; Equity Components= Common Stock; | ||
| 0001410578-25-001296 | 20250331 | Stockholders Equity | 1000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001410578-25-001296 | 20240331 | Stock Issued During Period Shares Stock Options Exercised | 55375.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001410578-25-001296 | 20240331 | Weighted Average Number Of Diluted Shares Outstanding | 19757449.0000 | shares | 1 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20250331 | Accrued Liabilities Current | 23011000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 1406000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001410578-25-001296 | 20240331 | Amortization Of Intangible Assets | 814000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20250331 | Assets Current | 53986000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 21070000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -3382000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20250331 | Common Stock Shares Issued | 6000000.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Common Class A; | ||
| 0001410578-25-001296 | 20250331 | Common Stock Shares Outstanding | 6000000.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Common Class A; | ||
| 0001410578-25-001296 | 20240331 | Cost Of Goods And Service Excluding Depreciation Depletion And Amortization | 6002000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20250331 | Cost Of Goods And Service Excluding Depreciation Depletion And Amortization | 4790000.0000 | USD | 1 | us-gaap/2024 | Consolidation Items= Operating Segments; | ||
| 0001410578-25-001296 | 20240331 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -10442000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20240331 | Increase Decrease In Account Payable Related Party | 3000.0000 | USD | 1 | 0001410578-25-001296 | |||
| 0001410578-25-001296 | 20240331 | Increase Decrease In Accounts Receivable | -5417000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20250331 | Intangible Assets Net Excluding Goodwill | 30798000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20241231 | Interest Payable Current | 404000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20250331 | Inventory Net | 12496000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20241231 | Liabilities Current | 35175000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20240331 | Net Income Loss | -10442000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001410578-25-001296 | 20241231 | Operating Lease Liability Noncurrent | 118000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20250331 | Operating Lease Right Of Use Asset | 178000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20250331 | Other Liabilities Current | 399000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20250331 | Proceeds From Issuance Of Common Stock | 4048000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20250331 | Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans | 99000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20240331 | Profit Loss | -10442000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20240331 | Provision For Doubtful Accounts | 6000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20250331 | Retained Earnings Accumulated Deficit | -91100000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 755000.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Amzeeq; | ||
| 0001410578-25-001296 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 1100000.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Amzeeq; | ||
| 0001410578-25-001296 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 2070000.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Emrosi; | ||
| 0001410578-25-001296 | 20250331 | Selling General And Administrative Expense | 10569000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20231231 | Shares Outstanding | 13323952.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001410578-25-001296 | 20240331 | Shares Outstanding | 13932310.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001410578-25-001296 | 20241231 | Stockholders Equity | 20069000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001410578-25-001296 | 20241231 | Stockholders Equity | 107094000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001410578-25-001296 | 20241231 | Stockholders Equity | -87027000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001410578-25-001296 | 20250331 | Stock Issued During Period Value Employee Stock Purchase Plan | 99000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001410578-25-001296 | 20240331 | Stock Issued During Period Value New Issues | 1484000.0000 | USD | 1 | us-gaap/2024 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| ddate | The end date for the data value, rounded to the nearest month end. |
| qtrs | The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value. |
| uom | The unit of measure for the value. |
| segments | Tags used to represent axis and member reporting. |
| coreg | If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity. |
| value | The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point. |
| footnote | The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank. |
| tag | version | custom | abstract | datatype | iord | crdr | tlabel | doc |
|---|---|---|---|---|---|---|---|---|
| Increase Decrease In Accounts Receivable | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Accounts Receivable | The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services. |
| Stock Issued During Period Value Stock Options Exercised | us-gaap/2024 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, Stock Options Exercised | Value of stock issued as a result of the exercise of stock options. |
| Amortization Of Debt Discount Premium | us-gaap/2024 | 0 | 0 | monetary | D | D | Amortization of Debt Discount (Premium) | Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense. |
| Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets, Current | Amount of asset recognized for present right to economic benefit, classified as current. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents | Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Increase Decrease In Interest Payable Net | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Interest Payable, Net | The increase (decrease) during the reporting period in interest payable, which represents the amount owed to note holders, bond holders, and other parties for interest earned on loans or credit extended to the reporting entity. |
| Operating Lease Liability Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Current | Present value of lessee's discounted obligation for lease payments from operating lease, classified as current. |
| Revenue From Contract With Customer Excluding Assessed Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | Revenue from Contract with Customer, Excluding Assessed Tax | Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. |
| Accounts Receivable Net Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Accounts Receivable, after Allowance for Credit Loss, Current | Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current. |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2024 | 0 | 0 | monetary | D | C | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. |
| Liabilities | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities | Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others. |
| Liabilities And Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities and Equity | Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. |
| Proceeds From Stock Options Exercised | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Stock Options Exercised | Amount of cash inflow from exercise of option under share-based payment arrangement. |
| Retained Earnings Accumulated Deficit | us-gaap/2024 | 0 | 0 | monetary | I | C | Retained Earnings (Accumulated Deficit) | Amount of accumulated undistributed earnings (deficit). |
| Additional Paid In Capital | us-gaap/2024 | 0 | 0 | monetary | I | C | Additional Paid in Capital | Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock. |
| Common Stock Par Or Stated Value Per Share | us-gaap/2024 | 0 | 0 | perShare | I | Common Stock, Par or Stated Value Per Share | Face amount or stated value per share of common stock. | |
| Common Stock Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Outstanding | Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. | |
| Net Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss) Attributable to Parent | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. |
| Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Equity, Attributable to Parent | Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest. |
| Stock Issued During Period Value Employee Stock Purchase Plan | us-gaap/2024 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, Employee Stock Purchase Plan | Aggregate change in value for stock issued during the period as a result of employee stock purchase plan. |
| Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Diluted | The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. | |
| Assets | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets | Amount of asset recognized for present right to economic benefit. |
| Common Stock Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Issued | Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. | |
| Earnings Per Share Diluted | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Diluted | The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. | |
| Interest Payable Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Interest Payable, Current | Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| Operating Lease Right Of Use Asset | us-gaap/2024 | 0 | 0 | monetary | I | D | Operating Lease, Right-of-Use Asset | Amount of lessee's right to use underlying asset under operating lease. |
| Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash and Cash Equivalents, at Carrying Value | Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. |
| Accrued Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Accrued Liabilities, Current | Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| Increase Decrease In Accrued Income Taxes Payable | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Income Taxes Payable | The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction. |
| Interest Expense Nonoperating | us-gaap/2024 | 0 | 0 | monetary | D | D | Interest Expense, Nonoperating | Amount of interest expense classified as nonoperating. |
| Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities, Current | Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. |
| Selling General And Administrative Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | Selling, General and Administrative Expense | The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc. |
| Share Based Compensation | us-gaap/2024 | 0 | 0 | monetary | D | D | Share-Based Payment Arrangement, Noncash Expense | Amount of noncash expense for share-based payment arrangement. |
| Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures | us-gaap/2024 | 0 | 0 | shares | D | Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures | Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited. | |
| Installment Payments Licenses Net Current | 0001410578-25-001296 | 1 | 0 | monetary | I | C | Installment Payments Licenses, Net Current | The amount of current portion of installment payment on licenses after imputed interest as at the end of the reporting period. |
| Foreign Currency Transaction Gain Loss Before Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | Gain (Loss), Foreign Currency Transaction, before Tax | Amount, before tax, of realized and unrealized gain (loss) from foreign currency transaction. |
| Increase Decrease In Inventories | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Inventories | The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities. |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Prepaid Expense and Other Assets | Amount of increase (decrease) in prepaid expenses, and assets classified as other. |
| Nonoperating Income Expense | us-gaap/2024 | 0 | 0 | monetary | D | C | Nonoperating Income (Expense) | The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). |
| Other Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Other Liabilities, Current | Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer. |
| Profit Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2024 | 0 | 0 | monetary | D | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Interest Income | 0001410578-25-001296 | 1 | 0 | monetary | D | C | Interest Income | Amount of interest income. |
| Accrued Income Taxes Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Accrued Income Taxes, Current | Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations. |
| Costs And Expenses | us-gaap/2024 | 0 | 0 | monetary | D | D | Costs and Expenses | Total costs of sales and operating expenses for the period. |
| Intangible Assets Net Excluding Goodwill | us-gaap/2024 | 0 | 0 | monetary | I | D | Intangible Assets, Net (Excluding Goodwill) | Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges. |
| Net Cash Provided By Used In Operating Activities | us-gaap/2024 | 0 | 0 | monetary | D | Net Cash Provided by (Used in) Operating Activities | Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. | |
| Operating Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Operating Income (Loss) | The net result for the period of deducting operating expenses from operating revenues. |
| Prepaid Expense And Other Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Prepaid Expense and Other Assets, Current | Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer. |
| Repayments Of Notes Payable | us-gaap/2024 | 0 | 0 | monetary | D | C | Repayments of Notes Payable | The cash outflow for a borrowing supported by a written promise to pay an obligation. |
| Sale Of Stock Stock Issuance Costs | 0001410578-25-001296 | 1 | 0 | monetary | D | D | Sale Of Stock, Stock Issuance Costs | Amount of stock issuance costs incurred during the period. |
| Common Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Common Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| Cost Of Goods And Service Excluding Depreciation Depletion And Amortization | us-gaap/2024 | 0 | 0 | monetary | D | D | Cost of Goods and Service, Excluding Depreciation, Depletion, and Amortization | Cost of product sold and service rendered, excluding depreciation, depletion, and amortization. |
| Inventory Net | us-gaap/2024 | 0 | 0 | monetary | I | D | Inventory, Net | Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer. |
| Research And Development Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | Research and Development Expense | Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. |
| Stock Issued During Period Shares New Issues | us-gaap/2024 | 0 | 0 | shares | D | Stock Issued During Period, Shares, New Issues | Number of new stock issued during the period. | |
| Accounts Payable Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Accounts Payable, Current | Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| Amortization Of Intangible Assets | us-gaap/2024 | 0 | 0 | monetary | D | D | Amortization of Intangible Assets | The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method. |
| Commitments And Contingencies | us-gaap/2024 | 0 | 0 | monetary | I | C | Commitments and Contingencies | Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur. |
| Common Stock Shares Authorized | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares Authorized | The maximum number of common shares permitted to be issued by an entity's charter and bylaws. | |
| Increase Decrease In Operating Lease Liability | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Operating Lease Liability | Amount of increase (decrease) in obligation for operating lease. |
| Increase Decrease In Accounts Payable | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accounts Payable | The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | us-gaap/2024 | 0 | 0 | monetary | D | C | APIC, Share-Based Payment Arrangement, Increase for Cost Recognition | Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement. |
| Interest Paid Net | us-gaap/2024 | 0 | 0 | monetary | D | C | Interest Paid, Excluding Capitalized Interest, Operating Activities | Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount. |
| Net Cash Provided By Used In Financing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Financing Activities | Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. |
| Operating Lease Right Of Use Asset Amortization Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | Operating Lease, Right-of-Use Asset, Periodic Reduction | Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease. |
| Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Shares, Outstanding | Number of shares issued which are neither cancelled nor held in the treasury. | |
| Earnings Per Share Basic | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Basic | The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. | |
| Proceeds From Issuance Of Common Stock | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Issuance of Common Stock | The cash inflow from the additional capital contribution to the entity. |
| Stock Issued During Period Shares Employee Stock Purchase Plans | us-gaap/2024 | 0 | 0 | shares | D | Stock Issued During Period, Shares, Employee Stock Purchase Plans | Number of shares issued during the period as a result of an employee stock purchase plan. | |
| Stock Issued During Period Shares Stock Options Exercised | us-gaap/2024 | 0 | 0 | shares | D | Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period | Number of share options (or share units) exercised during the current period. | |
| Stock Issued During Period Value New Issues | us-gaap/2024 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, New Issues | Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. |
| Increase Decrease In Account Payable Related Party | 0001410578-25-001296 | 1 | 0 | monetary | D | D | Increase Decrease In Account Payable Related Party | The increase (decrease) during the reporting period in the obligations due for goods and services provided by related parties. |
| Increase Decrease In Accrued Liabilities | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accrued Liabilities | The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid. |
| Operating Lease Liability Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Noncurrent | Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent. |
| Long Term Debt Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Long-Term Debt, Current Maturities | Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation. |
| Long Term Debt Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | C | Long-Term Debt, Excluding Current Maturities | Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation. |
| Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Excluding Option Exercised | Amount of cash inflow from issuance of shares under share-based payment arrangement. Excludes option exercised. |
| Provision For Doubtful Accounts | us-gaap/2024 | 0 | 0 | monetary | D | D | Accounts Receivable, Credit Loss Expense (Reversal) | Amount of expense (reversal of expense) for expected credit loss on accounts receivable. |
| Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Basic | Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. |
| Field Name | Field Description |
|---|---|
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| custom | 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns. |
| abstract | 1 if the tag is not used to represent a numeric fact. |
| datatype | If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag. |
| iord | If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration. |
| crdr | If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL. |
| tlabel | If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here. |
| doc | The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL. |
| adsh | report | line | stmt | inpth | rfile | tag | version | plabel | negating |
|---|---|---|---|---|---|---|---|---|---|
| 0001410578-25-001296 | 2 | 9 | BS | 0 | H | Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | Cash and cash equivalents | 0 |
| 0001410578-25-001296 | 2 | 10 | BS | 0 | H | Accounts Receivable Net Current | us-gaap/2024 | Accounts receivable, net of reserves | 0 |
| 0001410578-25-001296 | 2 | 11 | BS | 0 | H | Inventory Net | us-gaap/2024 | Inventory | 0 |
| 0001410578-25-001296 | 2 | 12 | BS | 0 | H | Prepaid Expense And Other Assets Current | us-gaap/2024 | Prepaid expenses and other current assets | 0 |
| 0001410578-25-001296 | 2 | 13 | BS | 0 | H | Assets Current | us-gaap/2024 | Total current assets | 0 |
| 0001410578-25-001296 | 2 | 14 | BS | 0 | H | Intangible Assets Net Excluding Goodwill | us-gaap/2024 | Intangible assets, net | 0 |
| 0001410578-25-001296 | 2 | 15 | BS | 0 | H | Operating Lease Right Of Use Asset | us-gaap/2024 | Operating lease right-of-use asset, net | 0 |
| 0001410578-25-001296 | 2 | 16 | BS | 0 | H | Assets | us-gaap/2024 | Total assets | 0 |
| 0001410578-25-001296 | 2 | 20 | BS | 0 | H | Accounts Payable Current | us-gaap/2024 | Accounts payable | 0 |
| 0001410578-25-001296 | 2 | 21 | BS | 0 | H | Other Liabilities Current | us-gaap/2024 | Due to related party | 0 |
| 0001410578-25-001296 | 2 | 23 | BS | 0 | H | Accrued Liabilities Current | us-gaap/2024 | Accrued expenses | 0 |
| 0001410578-25-001296 | 2 | 24 | BS | 0 | H | Interest Payable Current | us-gaap/2024 | Accrued interest | 0 |
| 0001410578-25-001296 | 2 | 25 | BS | 0 | H | Accrued Income Taxes Current | us-gaap/2024 | Income taxes payable | 0 |
| 0001410578-25-001296 | 2 | 26 | BS | 0 | H | Long Term Debt Current | us-gaap/2024 | Term loan - short-term | 0 |
| 0001410578-25-001296 | 2 | 27 | BS | 0 | H | Installment Payments Licenses Net Current | 0001410578-25-001296 | Installment payments - licenses, short-term | 0 |
| 0001410578-25-001296 | 2 | 28 | BS | 0 | H | Operating Lease Liability Current | us-gaap/2024 | Operating lease liability, short-term | 0 |
| 0001410578-25-001296 | 2 | 29 | BS | 0 | H | Liabilities Current | us-gaap/2024 | Total current liabilities | 0 |
| 0001410578-25-001296 | 2 | 30 | BS | 0 | H | Long Term Debt Noncurrent | us-gaap/2024 | Term loan - long-term, net of discount | 0 |
| 0001410578-25-001296 | 2 | 31 | BS | 0 | H | Operating Lease Liability Noncurrent | us-gaap/2024 | Operating lease liability, long-term | 0 |
| 0001410578-25-001296 | 2 | 32 | BS | 0 | H | Liabilities | us-gaap/2024 | Total liabilities | 0 |
| 0001410578-25-001296 | 2 | 33 | BS | 0 | H | Commitments And Contingencies | us-gaap/2024 | Commitments and contingencies (Note 13) | 0 |
| 0001410578-25-001296 | 2 | 35 | BS | 0 | H | Common Stock Value | us-gaap/2024 | Common stock | 0 |
| 0001410578-25-001296 | 2 | 36 | BS | 0 | H | Additional Paid In Capital | us-gaap/2024 | Additional paid-in capital | 0 |
| 0001410578-25-001296 | 2 | 37 | BS | 0 | H | Retained Earnings Accumulated Deficit | us-gaap/2024 | Accumulated deficit | 0 |
| 0001410578-25-001296 | 2 | 38 | BS | 0 | H | Stockholders Equity | us-gaap/2024 | Total stockholders' equity | 0 |
| 0001410578-25-001296 | 2 | 39 | BS | 0 | H | Liabilities And Stockholders Equity | us-gaap/2024 | Total liabilities and stockholders' equity | 0 |
| 0001410578-25-001296 | 3 | 7 | BS | 1 | H | Common Stock Par Or Stated Value Per Share | us-gaap/2024 | Par value | 0 |
| 0001410578-25-001296 | 3 | 8 | BS | 1 | H | Common Stock Shares Authorized | us-gaap/2024 | Common stock authorized | 0 |
| 0001410578-25-001296 | 3 | 9 | BS | 1 | H | Common Stock Shares Issued | us-gaap/2024 | Common stock issued | 0 |
| 0001410578-25-001296 | 3 | 10 | BS | 1 | H | Common Stock Shares Outstanding | us-gaap/2024 | Common stock outstanding | 0 |
| 0001410578-25-001296 | 4 | 2 | IS | 0 | H | Revenue From Contract With Customer Excluding Assessed Tax | us-gaap/2024 | Product revenue, net | 0 |
| 0001410578-25-001296 | 4 | 4 | IS | 0 | H | Cost Of Goods And Service Excluding Depreciation Depletion And Amortization | us-gaap/2024 | Cost of goods sold - (excluding amortization of acquired intangible assets) | 0 |
| 0001410578-25-001296 | 4 | 5 | IS | 0 | H | Amortization Of Intangible Assets | us-gaap/2024 | Amortization of acquired intangible assets | 0 |
| 0001410578-25-001296 | 4 | 6 | IS | 0 | H | Research And Development Expense | us-gaap/2024 | Research and development | 0 |
| 0001410578-25-001296 | 4 | 7 | IS | 0 | H | Selling General And Administrative Expense | us-gaap/2024 | Selling, general and administrative | 0 |
| 0001410578-25-001296 | 4 | 8 | IS | 0 | H | Costs And Expenses | us-gaap/2024 | Total operating expenses | 0 |
| 0001410578-25-001296 | 4 | 9 | IS | 0 | H | Operating Income Loss | us-gaap/2024 | Loss from operations | 0 |
| 0001410578-25-001296 | 4 | 11 | IS | 0 | H | Interest Income | 0001410578-25-001296 | Interest income | 1 |
| 0001410578-25-001296 | 4 | 12 | IS | 0 | H | Interest Expense Nonoperating | us-gaap/2024 | Interest expense | 0 |
| 0001410578-25-001296 | 4 | 13 | IS | 0 | H | Foreign Currency Transaction Gain Loss Before Tax | us-gaap/2024 | Foreign exchange transaction losses | 1 |
| 0001410578-25-001296 | 4 | 14 | IS | 0 | H | Nonoperating Income Expense | us-gaap/2024 | Total other expense (income) | 1 |
| 0001410578-25-001296 | 4 | 15 | IS | 0 | H | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2024 | Loss before income taxes | 0 |
| 0001410578-25-001296 | 4 | 16 | IS | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
| 0001410578-25-001296 | 4 | 18 | IS | 0 | H | Earnings Per Share Basic | us-gaap/2024 | Basic (In dollars per share) | 0 |
| 0001410578-25-001296 | 4 | 19 | IS | 0 | H | Earnings Per Share Diluted | us-gaap/2024 | Diluted (In dollars per share) | 0 |
| 0001410578-25-001296 | 4 | 21 | IS | 0 | H | Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | Basic (In shares) | 0 |
| 0001410578-25-001296 | 4 | 22 | IS | 0 | H | Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | Diluted (In shares) | 0 |
| 0001410578-25-001296 | 5 | 12 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Balance at beginning | 0 |
| 0001410578-25-001296 | 5 | 13 | EQ | 0 | H | Shares Outstanding | us-gaap/2024 | Balance at beginning (in shares) | 0 |
| 0001410578-25-001296 | 5 | 14 | EQ | 0 | H | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | us-gaap/2024 | Share-based compensation | 0 |
| 0001410578-25-001296 | 5 | 15 | EQ | 0 | H | Stock Issued During Period Value Stock Options Exercised | us-gaap/2024 | Exercise of stock options for cash | 0 |
| 0001410578-25-001296 | 5 | 16 | EQ | 0 | H | Stock Issued During Period Shares Stock Options Exercised | us-gaap/2024 | Exercise of stock options for cash (In shares) | 0 |
| 0001410578-25-001296 | 5 | 17 | EQ | 0 | H | Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures | us-gaap/2024 | Issuance of common stock for vested restricted stock units (in shares) | 0 |
| 0001410578-25-001296 | 5 | 18 | EQ | 0 | H | Stock Issued During Period Value Employee Stock Purchase Plan | us-gaap/2024 | Issuance of common stock under ESPP | 0 |
| 0001410578-25-001296 | 5 | 19 | EQ | 0 | H | Stock Issued During Period Shares Employee Stock Purchase Plans | us-gaap/2024 | Issuance of common stock under ESPP (in shares) | 0 |
| 0001410578-25-001296 | 5 | 20 | EQ | 0 | H | Stock Issued During Period Value New Issues | us-gaap/2024 | Issuance of common stock, ATM offering, net of issuance costs | 0 |
| 0001410578-25-001296 | 5 | 21 | EQ | 0 | H | Stock Issued During Period Shares New Issues | us-gaap/2024 | Issuance of common stock, ATM offering, net of issuance costs (in shares) | 0 |
| 0001410578-25-001296 | 5 | 22 | EQ | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
| 0001410578-25-001296 | 5 | 23 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Balance at ending | 0 |
| 0001410578-25-001296 | 5 | 24 | EQ | 0 | H | Shares Outstanding | us-gaap/2024 | Balance at ending (in shares) | 0 |
| 0001410578-25-001296 | 6 | 1 | EQ | 1 | H | Sale Of Stock Stock Issuance Costs | 0001410578-25-001296 | Stock issuance costs | 0 |
| 0001410578-25-001296 | 7 | 2 | CF | 0 | H | Profit Loss | us-gaap/2024 | Net loss | 0 |
| 0001410578-25-001296 | 7 | 4 | CF | 0 | H | Provision For Doubtful Accounts | us-gaap/2024 | Bad debt expense | 0 |
| 0001410578-25-001296 | 7 | 5 | CF | 0 | H | Amortization Of Debt Discount Premium | us-gaap/2024 | Amortization of debt discount | 0 |
| 0001410578-25-001296 | 7 | 6 | CF | 0 | H | Amortization Of Intangible Assets | us-gaap/2024 | Amortization of acquired intangible assets | 0 |
| 0001410578-25-001296 | 7 | 7 | CF | 0 | H | Operating Lease Right Of Use Asset Amortization Expense | us-gaap/2024 | Amortization of operating lease right-of-use assets | 0 |
| 0001410578-25-001296 | 7 | 8 | CF | 0 | H | Share Based Compensation | us-gaap/2024 | Share-based compensation | 0 |
| 0001410578-25-001296 | 7 | 10 | CF | 0 | H | Increase Decrease In Accounts Receivable | us-gaap/2024 | Accounts receivable | 1 |
| 0001410578-25-001296 | 7 | 11 | CF | 0 | H | Increase Decrease In Inventories | us-gaap/2024 | Inventory | 1 |
| 0001410578-25-001296 | 7 | 12 | CF | 0 | H | Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2024 | Prepaid expenses and other current assets | 1 |
| 0001410578-25-001296 | 7 | 13 | CF | 0 | H | Increase Decrease In Accounts Payable | us-gaap/2024 | Accounts payable | 0 |
| 0001410578-25-001296 | 7 | 14 | CF | 0 | H | Increase Decrease In Account Payable Related Party | 0001410578-25-001296 | Due to related party | 0 |
| 0001410578-25-001296 | 7 | 15 | CF | 0 | H | Increase Decrease In Accrued Liabilities | us-gaap/2024 | Accrued expenses | 0 |
| 0001410578-25-001296 | 7 | 16 | CF | 0 | H | Increase Decrease In Interest Payable Net | us-gaap/2024 | Accrued interest | 0 |
| 0001410578-25-001296 | 7 | 17 | CF | 0 | H | Increase Decrease In Accrued Income Taxes Payable | us-gaap/2024 | Income tax payable | 0 |
| 0001410578-25-001296 | 7 | 18 | CF | 0 | H | Increase Decrease In Operating Lease Liability | us-gaap/2024 | Lease liabilities | 0 |
| 0001410578-25-001296 | 7 | 19 | CF | 0 | H | Net Cash Provided By Used In Operating Activities | us-gaap/2024 | Net cash used in operating activities | 0 |
| 0001410578-25-001296 | 7 | 21 | CF | 0 | H | Proceeds From Stock Options Exercised | us-gaap/2024 | Proceeds from exercise of stock options | 0 |
| 0001410578-25-001296 | 7 | 22 | CF | 0 | H | Proceeds From Issuance Of Common Stock | us-gaap/2024 | Proceeds from issuance of common stock, ATM offering, net of issuance costs | 0 |
| 0001410578-25-001296 | 7 | 23 | CF | 0 | H | Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans | us-gaap/2024 | Issuance of common stock under ESPP | 0 |
| 0001410578-25-001296 | 7 | 25 | CF | 0 | H | Repayments Of Notes Payable | us-gaap/2024 | Payments of license installment note payable | 1 |
| 0001410578-25-001296 | 7 | 26 | CF | 0 | H | Net Cash Provided By Used In Financing Activities | us-gaap/2024 | Net cash provided by financing activities | 0 |
| 0001410578-25-001296 | 7 | 27 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2024 | Net change in cash | 0 |
| 0001410578-25-001296 | 7 | 28 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash at the beginning of the period | 0 |
| 0001410578-25-001296 | 7 | 29 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash at the end of the period | 0 |
| 0001410578-25-001296 | 7 | 31 | CF | 0 | H | Interest Paid Net | us-gaap/2024 | Cash paid for interest | 0 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| report | Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site. |
| line | Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived. |
| stmt | The financial statement location to which the value of the “report” field pertains. |
| inpth | Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700. |
| rfile | The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file. |
| tag | The tag chosen by the filer for this line item. |
| version | The taxonomy identifier if the tag is a standard tag, otherwise adsh. |
| plabel | The text presented on the line item, also known as a “preferred” label. |
| negating | Flag to indicate whether the plabel is negating. |